These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34985049)

  • 41. The incidence and predictors of post transarterial chemoembolization variceal bleeding in hepatocellular carcinoma patients.
    Lin PT; Teng W; Jeng WJ; Hsieh YC; Hung CF; Huang CH; Lui KW; Chen YC; Lin CC; Lin SM; Sheen IS; Lin CY
    J Formos Med Assoc; 2020 Feb; 119(2):635-643. PubMed ID: 31495543
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distinctive Features and Outcomes of Hepatocellular Carcinoma in Patients With Alcohol-Related Liver Disease: A US Multicenter Study.
    deLemos A; Patel M; Gawrieh S; Burney H; Dakhoul L; Miller E; Scanga A; Kettler C; Liu H; Roche P; Wattacheril J; Chalasani N
    Clin Transl Gastroenterol; 2020 Mar; 11(3):e00139. PubMed ID: 32352723
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk factors of early re-bleeding and mortality in patients with ruptured gastric varices and concomitant hepatocellular carcinoma.
    Chang CJ; Hou MC; Liao WC; Lee FY; Lin HC; Lee SD
    J Gastroenterol; 2012 May; 47(5):531-9. PubMed ID: 22223176
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hospital-level balloon tamponade use is associated with increased mortality for all patients presenting with acute variceal haemorrhage.
    Tapper EB; Ezaz G; Patwardhan V; Mellinger J; Bonder A; Curry M; Saini SD
    Liver Int; 2018 Mar; 38(3):477-483. PubMed ID: 28837249
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?
    Edenvik P; Davidsdottir L; Oksanen A; Isaksson B; Hultcrantz R; Stål P
    Liver Int; 2015 Jul; 35(7):1862-71. PubMed ID: 25524812
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disease spectrum of alcoholic liver disease in Beijing 302 Hospital from 2002 to 2013: A large tertiary referral hospital experience from 7422 patients.
    Huang A; Chang B; Sun Y; Lin H; Li B; Teng G; Zou ZS
    Medicine (Baltimore); 2017 Feb; 96(7):e6163. PubMed ID: 28207552
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidemiological profile of alcoholic liver disease hospital admissions in a Latin American country over a 10-year period.
    Lyra AC; de Almeida LMC; Mise YF; Cavalcante LN
    World J Hepatol; 2020 May; 12(5):230-238. PubMed ID: 32547690
    [TBL] [Abstract][Full Text] [Related]  

  • 48. National survey of hepatocellular carcinoma in heavy drinkers in Japan.
    Horie Y; Yamagishi Y; Kajihara M; Kato S; Ishii H
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):32S-36S. PubMed ID: 12960504
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidemiology of Alcohol-Associated Liver Disease.
    Han S; Yang Z; Zhang T; Ma J; Chandler K; Liangpunsakul S
    Clin Liver Dis; 2021 Aug; 25(3):483-492. PubMed ID: 34229835
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hospital discharges of hepatocellular carcinoma and non-alcohol related cirrhosis in the EU/EEA and United Kingdom: a descriptive analysis of 2004-2015 data.
    Nakitanda AO; Duffell E
    Infect Dis (Lond); 2020 Nov; 52(11):816-827. PubMed ID: 32838640
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alcohol-related liver disease phenotype impacts survival after an acute variceal bleeding episode.
    Villagrasa A; Hernández-Gea V; Bataller R; Giráldez Á; Procopet B; Amitrano L; Villanueva C; Thabut D; Ibañez-Samaniego L; Albillos A; Bureau C; Trebicka J; Llop E; Laleman W; Palazon JM; Castellote J; Rodrigues S; Gluud LL; Ferreira CN; Cañete N; Rodríguez M; Ferlitsch A; Mundi JL; Gronbaek H; Hernández-Guerra M; Sassatelli R; Dell'Era A; Senzolo M; Abraldes JG; Zipprich A; Casas M; Masnou H; Primignani M; Krag A; Silva-Junior G; Romero-Gómez M; Tantau M; Guardascione MA; Alvarado E; Rudler M; Bañares R; Martinez J; Robic MA; Jansen C; Calleja JL; Nevens F; Bosch J; Ventura-Cots M; García-Pagan JC; Genescà J;
    Liver Int; 2023 Jul; 43(7):1548-1557. PubMed ID: 37183551
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Falling Rates of Hospital Admissions for Alcoholic Liver Disease in Northeast Italy: A Retrospective Study on a Large Database.
    Caroli D; Rosa-Rizzotto E; Pilerci C; Lobello S; De Lazzari F; Saia M
    Alcohol Alcohol; 2019 Dec; 54(6):662-666. PubMed ID: 31566688
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical characteristics of 4132 patients with alcoholic liver disease].
    Zhu B; Liu H; Liu L; Rong Y; Zang H; Liu W; You S; Xin S
    Zhonghua Gan Zang Bing Za Zhi; 2015 Sep; 23(9):680-3. PubMed ID: 26524362
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary Prophylaxis for Variceal Bleeding and the Improved Survival of Patients with Newly Diagnosed Hepatocellular Carcinoma.
    Kim JH; Sinn DH; Kim K; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Dig Dis Sci; 2016 Nov; 61(11):3354-3362. PubMed ID: 27435325
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endoscopic therapy for bleeding esophageal varices improves the outcome of Child C cirrhotic patients.
    Hori S; Takaki A; Okada H; Fujiwara A; Takenaka R; Makidono C; Shiratori Y
    J Gastroenterol Hepatol; 2006 Nov; 21(11):1704-9. PubMed ID: 16984593
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009.
    Younossi ZM; Otgonsuren M; Henry L; Venkatesan C; Mishra A; Erario M; Hunt S
    Hepatology; 2015 Dec; 62(6):1723-30. PubMed ID: 26274335
    [TBL] [Abstract][Full Text] [Related]  

  • 57. AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease.
    Beale G; Chattopadhyay D; Gray J; Stewart S; Hudson M; Day C; Trerotoli P; Giannelli G; Manas D; Reeves H
    BMC Cancer; 2008 Jul; 8():200. PubMed ID: 18638391
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk of hepatocellular carcinoma in Danish outpatients with alcohol-related cirrhosis.
    Jepsen P; Kraglund F; West J; Villadsen GE; Sørensen HT; Vilstrup H
    J Hepatol; 2020 Nov; 73(5):1030-1036. PubMed ID: 32512015
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical Patterns and Outcome of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease.
    Ahn SY; Kim SB; Song IH
    Can J Gastroenterol Hepatol; 2020; 2020():4873875. PubMed ID: 32566546
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diabetes Is Associated with Clinical Decompensation Events in Patients with Cirrhosis.
    Liu TL; Trogdon J; Weinberger M; Fried B; Barritt AS
    Dig Dis Sci; 2016 Nov; 61(11):3335-3345. PubMed ID: 27480088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.